Nationwide Fund Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-120,086
Closed -$9.15M 2565
2017
Q3
$9.15M Buy
120,086
+54,385
+83% +$4.11M 0.04% 702
2017
Q2
$4.93M Buy
65,701
+21,580
+49% +$1.5M 0.02% 1022
2017
Q1
$2.88M Buy
44,121
+1,723
+4% +$101K 0.01% 1256
2016
Q4
$2.34M Buy
42,398
+12,062
+40% +$662K 0.01% 1347
2016
Q3
$1.71M Buy
30,336
+14,370
+90% +$705K 0.01% 1474
2016
Q2
$667K Buy
15,966
+3,007
+23% +$139K ﹤0.01% 1978
2016
Q1
$554K Sell
12,959
-17,323
-57% -$732K ﹤0.01% 2038
2015
Q4
$1.37M Sell
30,282
-13
-0% -$546 0.01% 1553
2015
Q3
$1.18M Sell
30,295
-12,585
-29% -$504K 0.01% 1644
2015
Q2
$1.56M Sell
42,880
-765
-2% -$24.2K 0.01% 1586
2015
Q1
$1.26M Buy
43,645
+11,866
+37% +$331K 0.01% 1771
2014
Q4
$770K Buy
+31,779
New +$716K ﹤0.01% 1944

Other funds holding PRAH

Nationwide Fund Advisors's PRAH Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 120,086 shares — an estimated $9.15M sold.

Nationwide Fund Advisors first reported a position in PRAH in Q4 2014 and held it in 12 quarters. The position peaked at $9.15M in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 120,086 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $9.15M.
  • Nationwide Fund Advisors first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's PRA Health Sciences, Inc. position peaked at $9.15M in Q3 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.